๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Expression of cortactin and survivin in renal cell carcinoma associated with tumor aggressiveness

โœ Scribed by Giueng-Chueng Wang; Po-Shiuan Hsieh; Hsian-He Hsu; Guang-Huan Sun; Shin Nieh; Cheng-Ping Yu; Jong-Shiaw Jin

Publisher
Springer-Verlag
Year
2009
Tongue
English
Weight
579 KB
Volume
27
Category
Article
ISSN
0724-4983

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Survivin expression is associated with f
Survivin expression is associated with features of biologically aggressive prostate carcinoma
โœ Shahrokh F. Shariat; Yair Lotan; Hossein Saboorian; Seyed M. Khoddami; Claus G. ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 220 KB

## Abstract ## BACKGROUND Survivin counteracts cell death and controls mitotic progression. The objectives of the current study were to compare the expression patterns of survivin in normal prostate, primary prostate carcinoma, and lymph node tissues involved with prostate carcinoma and to determi

Low CAIX expression and absence of VHL g
Low CAIX expression and absence of VHL gene mutation are associated with tumor aggressiveness and poor survival of clear cell renal cell carcinoma
โœ Jean-Jacques Patard; Patricia Fergelot; Pierre I. Karakiewicz; Tobias Klatte; Qu ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 150 KB ๐Ÿ‘ 1 views

## Abstract We attempted to describe, in a series of clear cell renal cell carcinoma (RCC), the relationship between CAIX expression, VHL gene mutations, tumor characteristics and outcome. Radical nephrectomy was performed in 100 patients. Genomic DNA was extracted from frozen tumor samples. Four a

Distinct in vivo expression patterns of
Distinct in vivo expression patterns of survivin splice variants in renal cell carcinomas
โœ Csaba Mahotka; Thomas Krieg; Andreas Krieg; Michael Wenzel; Christoph V. Suschek ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 312 KB

## Abstract Survivin, a novel member of the inhibitor of apoptosis protein (IAP) family, reduces the susceptibility of tumor cells to proapoptotic stimuli, thereby promoting tumor cell survival during tumor progression and treatment with anticancer drugs. Recently, we identified 2 novel alternative

High expression of EZH2 is associated wi
High expression of EZH2 is associated with tumor aggressiveness and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy
โœ Li-Ru He; Meng-Zhong Liu; Bin-Kui Li; Wei-Hua Jia; Ying Zhang; Yi-Ji Liao; Yang- ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 498 KB ๐Ÿ‘ 1 views

## Abstract The enhancer of zeste homolog 2 (EZH2), a known repressor of gene transcription, has been reported to be associated with biological malignancy in several cancers. The potential oncogenic role of EZH2 and its clinical/prognostic significance, however, in esophageal squamous cell carcinom